fig1
![Hepatocellular carcinoma surveillance in non-alcoholic fatty liver disease patients](https://image.oaes.cc/f8315024-8218-43e3-a313-da8810ffaa02/5285.fig.1.jpg)
Figure 1. Recommendations for HCC Surveillance in NAFLD. AFP: α-fetoprotein; CT: computed tomography; HCC: hepatocellular carcinoma; LI-RADS: liver imaging reporting and data system; MRI: magnetic resonance imaging; NAFLD: non-alcoholic fatty liver disease; US: ultrasonography.